FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)
Completed · Not applicable
Conditions studied: Type 1 Diabetes
In brief
The purpose of this study is to see if a behavioral intervention for adolescents with type 1 diabetes will improve adherence to T1D self-management activities and improve diabetes outcomes. We expect the intervention to improve diabetes outcomes when compared to usual care.
Key facts
- Study ID
- NCT01286350
- Run by
- University of North Carolina, Chapel Hill
- People needed
- 258
- Starts
- 2014-05-01
- Expected to finish
- 2018-01-01
- Last updated by the study team
- 2021-04-29
Who can join
Age: 13 and older, up to 16. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- type 1 diabetes with duration at least 12 months
- between ages 12-16 years at registration
- poor glycemic control (A1c 8.0-13.0%)
- parent/guardian willing to also participate
- not planning on moving in the following 18 months
You may not qualify if…
- pregnant (if female)
- diabetes type 2 or gestational
- Pre-existing systemic chronic disease (drug abuse, cancer, certain psychiatric conditions)
Where it is running
- University of Colorado Barbara Davis Center for Childhood Diabetes — Aurora, Colorado, United States
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.